Insider Transactions in Q4 2023 at Royalty Pharma PLC (RPRX)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2023
|
Avara Management LTD |
SELL
Open market or private sale
|
Indirect |
65,803
-2.59%
|
$1,842,484
$28.04 P/Share
|
|
Dec 29
2023
|
Bonnie L Bassler Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,353
+2.83%
|
$36,531
$27.71 P/Share
|
|
Dec 29
2023
|
Henry A Fernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,353
+3.22%
|
$36,531
$27.71 P/Share
|
|
Dec 28
2023
|
Avara Management LTD |
SELL
Open market or private sale
|
Indirect |
209,863
-7.62%
|
$5,876,164
$28.2 P/Share
|
|
Dec 27
2023
|
Avara Management LTD |
SELL
Open market or private sale
|
Indirect |
41,729
-1.49%
|
$1,168,412
$28.01 P/Share
|
|
Dec 15
2023
|
Avara Management LTD |
SELL
Open market or private sale
|
Indirect |
10,229
-0.36%
|
$286,412
$28.01 P/Share
|
|
Dec 14
2023
|
Avara Management LTD |
SELL
Open market or private sale
|
Indirect |
364,441
-11.5%
|
$10,204,348
$28.91 P/Share
|
|
Dec 13
2023
|
Avara Management LTD |
SELL
Open market or private sale
|
Indirect |
307,935
-8.86%
|
$8,622,180
$28.95 P/Share
|
|
Nov 16
2023
|
Legorreta Pablo G. CEO, Chairman of the Board |
SELL
Other acquisition or disposition
|
Direct |
383,000
-85.72%
|
-
|
|
Nov 13
2023
|
George W. Lloyd EVP, Investments & CLO |
BUY
Conversion of derivative security
|
Indirect |
150,000
+34.86%
|
-
|
|
Nov 13
2023
|
Rory B Riggs Director |
BUY
Conversion of derivative security
|
Direct |
475,590
+49.25%
|
-
|